Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVPH Reviva Pharmaceuticals Holdings, Inc.

休市中 04-24 16:00:00 EDT

0.9004

+0.0111

+1.25%

盘后0.8850

-0.0154-1.71%

19:54 EDT

最高0.9169	最低0.8670	成交量19.11万
今开0.9100	昨收0.8893	日振幅5.61%
总市值1,146万	流通市值1,130万	总股本1,273万
成交额17.19万	换手率1.52%	流通股本1,255万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":0.9004,"timestamp":1777060800000,"preClose":0.8893,"halted":0,"volume":191101,"hourTrading":{"tag":"盘后","latestPrice":0.885,"preClose":0.9004,"latestTime":"19:54 EDT","volume":3355,"amount":3019.0518,"timestamp":1777074861089,"change":-0.0154,"changeRate":-0.017104,"amplitude":0.03554},"delay":0,"changeRate":0.012481727201169458,"floatShares":12551300,"shares":12727000,"eps":-5.479999,"marketStatus":"休市中","change":0.0111,"latestTime":"04-24 16:00:00 EDT","open":0.91,"high":0.9169,"low":0.867,"amount":171928.83995025,"amplitude":0.056112,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.479999,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8893,"preHourTrading":{"tag":"盘前","latestPrice":0.9169,"preClose":0.8893,"latestTime":"09:17 EDT","volume":3166,"amount":2889.3617269,"timestamp":1777036672843,"change":0.0276,"changeRate":0.031036,"amplitude":0.034522},"postHourTrading":{"tag":"盘后","latestPrice":0.885,"preClose":0.9004,"latestTime":"19:54 EDT","volume":3355,"amount":3019.0518,"timestamp":1777074861089,"change":-0.0154,"changeRate":-0.017104,"amplitude":0.03554},"volumeRatio":0.40287031779651944,"impliedVol":1.3471,"impliedVolPercentile":0.5459},"requestUrl":"/m/hq/s/RVPH","defaultTab":"news","newsList":[{"id":"1180339579","title":"Reviva制药控股宣布Recover-2研究计划：2026年Q2启动试验活动，Q3开始患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1180339579","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180339579?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:10","pubTimestamp":1776255015,"startTime":"0","endTime":"0","summary":"根据最新SEC文件披露，Reviva Pharmaceuticals Holdings, Inc. (简称Reviva制药控股) 已正式规划其关键临床研究Recover-2的推进时间表。该公司计划于2026年第二季度启动相关试验活动，随后在第三季度正式开始患者招募工作。\n这一重要进展标志着Reviva制药控股在推进其研发管线方面迈出实质性步伐。Recover-2研究的顺利开展将对公司未来发展产生深远影响，为后续临床开发奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153315660","title":"Reviva制药拟启动公开发行，募资推进精神分裂症三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1153315660","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153315660?lang=zh_cn&edition=full","pubTime":"2026-03-19 04:13","pubTimestamp":1773864804,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc.于2026年3月18日宣布，计划进行公开发行，出售其普通股及认股权证。本次发行全部由公司自身售股，最终完成将取决于市场及其他条件，发行规模与具体条款尚存不确定性。A.G.P./Alliance Global Partners担任此次发行的独家配售代理。公司计划将本次发行净收益连同现有现金及等价物，用于资助研发活动，其中包括brilaroxazine治疗精神分裂症的RECOVER-2三期临床试验，以及营运资本和其他一般企业用途。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH","BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616980392","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨5.78%报0.227美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616980392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616980392?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:16","pubTimestamp":1772464595,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日23时16分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅拉升5.78%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Anebulo Pharmaceuticals, Inc.、Rallybio Corporation、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Rallybio Corporation较为活跃，换手率分别为107.62%、46.33%、38.95%，振幅较大的相关个股有Anebulo Pharmaceuticals, Inc.、Edesa Biotech, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为38.89%、27.27%、26.79%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603022316369542a46a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603022316369542a46a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191988294","title":"Reviva公布Brilaroxazine治疗精神分裂症阴性症状的RECOVER三期临床试验中临床声音生物标志物数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1191988294","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191988294?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:02","pubTimestamp":1767877356,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc. (简称Reviva) 近日宣布，其针对精神分裂症阴性症状治疗药物Brilaroxazine的RECOVER三期临床试验中，有关临床声音生物标志物的数据已正式发表。\n该数据的发布标志着在利用声音特征作为生物标志物评估精神分裂症患者治疗反应方面取得了重要进展。Brilaroxazine作为一种创新疗法，其临床试验数据备受业界关注。\n此次发表的数据将进一步推动精神分裂症治疗领域的研究，为临床医生提供新的评估工具和治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595647779","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 快速下挫5.17%报0.275美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595647779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595647779?lang=zh_cn&edition=full","pubTime":"2025-12-31 01:32","pubTimestamp":1767115976,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日01时32分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速下挫5.17%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，健永生技、Dermata Therapeutics, Inc.、Impact Biomedical, Inc.涨幅较大，Dermata Therapeutics, Inc.、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为2005.07%、694.28%、45.11%，振幅较大的相关个股有健永生技、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cdt Equity Inc C/Wts 22/09/2028，振幅分别为43.17%、38.46%、38.46%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123101325697a0df29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123101325697a0df29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593547165","title":"Reviva Pharmaceuticals Holdings, Inc.股价重挫50.58% 市值跌1697.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593547165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593547165?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:31","pubTimestamp":1766500290,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时31分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价大幅下跌50.58%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Chemomab Therapeutics Ltd、Genenta Science Spa、Neurosense Therapeutics Ltd.涨幅较大，Lexaria Bioscience Corp.、Pmgc Holdings Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为61.25%、16.65%、13.91%，振幅较大的相关个股有Chemomab Therapeutics Ltd、Radiopharm Theranostics Limited、Lexaria Bioscience Corp.，振幅分别为15.46%、10.88%、7.58%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223130a46f57f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223130a46f57f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172843312","title":"Reviva发布关于Brilaroxazine治疗精神分裂症的开发监管更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1172843312","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172843312?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:01","pubTimestamp":1766494869,"startTime":"0","endTime":"0","summary":"Reviva发布关于Brilaroxazine治疗精神分裂症的开发监管更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102650137","title":"Reviva获得欧洲专利，涵盖Brilaroxazine在肺纤维化治疗中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1102650137","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102650137?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:03","pubTimestamp":1762779802,"startTime":"0","endTime":"0","summary":"Reviva获得欧洲专利，涵盖Brilaroxazine在肺纤维化治疗中的应用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579816604","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨6.39%报0.614美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579816604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579816604?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:43","pubTimestamp":1761745405,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日21时43分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价急速拉升6.39%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。消息层面，截至21时43分，《H.C. Wainwright维持Reviva Pharmaceuticals买入评级，下调目标价至4美元》资讯为影响Reviva Pharmaceuticals Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510292143259748a245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510292143259748a245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143839042","title":"Reviva将在2025年CNS峰会上发布关于Brilaroxazine在精神分裂症中负面症状的数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1143839042","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143839042?lang=zh_cn&edition=full","pubTime":"2025-10-28 20:04","pubTimestamp":1761653041,"startTime":"0","endTime":"0","summary":"Reviva将在2025年CNS峰会上发布关于Brilaroxazine在精神分裂症中负面症状的数据，该数据来自于第三阶段Recover双盲及开放标签延伸试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222679","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222679?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613544,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速上涨5.72%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2021.99%、400.44%、56.95%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213225964035f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213225964035f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517921870","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 快速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517921870?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:49","pubTimestamp":1741207780,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时49分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价大幅拉升5.20%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为986.43%、322.35%、320.80%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为497.01%、82.59%、54.27%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044940989d96e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044940989d96e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516658394","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658394?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:44","pubTimestamp":1741016666,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时44分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价急速跳水5.21%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2480.50%、138.40%、131.06%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、50.09%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032344269637bee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032344269637bee8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516305960","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.59%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516305960?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:29","pubTimestamp":1740770981,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时29分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速跳水5.59%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Camp4 Therapeutics Corporation、Enveric Biosciences, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3225.84%、582.90%、385.74%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301032941a2584663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301032941a2584663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514717862","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 临近收盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514717862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514717862?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:35","pubTimestamp":1740602139,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时35分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价快速下跌5.32%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6867.43%、345.22%、265.44%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043539abde3bdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043539abde3bdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514014242","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫5.14%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514014242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514014242?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:59","pubTimestamp":1740502783,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时59分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速下挫5.14%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1522.34%、1124.86%、941.30%，振幅较大的相关个股有Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp，振幅分别为241.19%、112.90%、87.83%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226005943abdca0bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226005943abdca0bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513772095","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513772095?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:59","pubTimestamp":1740409189,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时59分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅下跌5.10%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为150.95%、65.71%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225950a2521b51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225950a2521b51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513242211","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513242211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513242211?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:42","pubTimestamp":1740166941,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时42分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价快速下挫5.21%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为310.86%、249.92%、137.93%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222034221abd7eeb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222034221abd7eeb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512486950","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.16%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512486950?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:13","pubTimestamp":1739977994,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时13分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅下跌5.16%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为414.78%、230.33%、117.85%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、148.23%、36.97%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231314abd50976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231314abd50976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511969473","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速跳水5.00%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511969473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511969473?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:29","pubTimestamp":1739546952,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时29分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价快速跳水5.00%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2478.03%、642.18%、479.73%，振幅较大的相关个股有Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为66.93%、54.40%、43.67%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232912962328ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232912962328ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revivapharma.com","stockEarnings":[{"period":"1week","weight":0.0593},{"period":"1month","weight":0.0868},{"period":"3month","weight":-0.8619},{"period":"6month","weight":-0.9333},{"period":"1year","weight":-0.95},{"period":"ytd","weight":-0.8386}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Reviva Pharmaceuticals Holdings, Inc.于2018年3月20日在英属维尔京群岛注册成立。该公司是一家后期制药公司，致力于发现、开发并寻求将下一代治疗方法商业化，以治疗那些对社会、患者及其家庭具有重大未满足医疗需求和负担的疾病。他们目前的产品线主要集中在中枢神经系统、炎症和心脏代谢疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":-0.062378},{"month":2,"riseRate":0.5,"avgChangeRate":-0.031414},{"month":3,"riseRate":0.25,"avgChangeRate":-0.173427},{"month":4,"riseRate":0.625,"avgChangeRate":0.060589},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.121668},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.157351},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.108029},{"month":8,"riseRate":0.428571,"avgChangeRate":0.349869},{"month":9,"riseRate":0.428571,"avgChangeRate":0.001903},{"month":10,"riseRate":0.571429,"avgChangeRate":0.244305},{"month":11,"riseRate":0.5,"avgChangeRate":-0.018447},{"month":12,"riseRate":0.625,"avgChangeRate":0.007569}],"exchange":"NASDAQ","name":"Reviva Pharmaceuticals Holdings, Inc.","nameEN":"Reviva Pharmaceuticals Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Reviva Pharmaceuticals Holdings, Inc.(RVPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Reviva Pharmaceuticals Holdings, Inc.,RVPH,Reviva Pharmaceuticals Holdings, Inc.股票,Reviva Pharmaceuticals Holdings, Inc.股票老虎,Reviva Pharmaceuticals Holdings, Inc.股票老虎国际,Reviva Pharmaceuticals Holdings, Inc.行情,Reviva Pharmaceuticals Holdings, Inc.股票行情,Reviva Pharmaceuticals Holdings, Inc.股价,Reviva Pharmaceuticals Holdings, Inc.股市,Reviva Pharmaceuticals Holdings, Inc.股票价格,Reviva Pharmaceuticals Holdings, Inc.股票交易,Reviva Pharmaceuticals Holdings, Inc.股票购买,Reviva Pharmaceuticals Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Reviva Pharmaceuticals Holdings, Inc.(RVPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}